Norges Bank acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 2,764,168 shares of the company’s stock, valued at approximately $55,504,000.
Several other institutional investors and hedge funds have also modified their holdings of BBWI. Royal Bank of Canada lifted its stake in shares of Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after purchasing an additional 28,815 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after purchasing an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after purchasing an additional 36,684 shares during the last quarter. Intech Investment Management LLC acquired a new stake in shares of Bath & Body Works in the 1st quarter valued at $1,155,000. Finally, Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
Analysts Set New Price Targets
Several research analysts recently commented on the stock. Piper Sandler assumed coverage on shares of Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price on the stock. Weiss Ratings downgraded shares of Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. UBS Group dropped their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Telsey Advisory Group dropped their target price on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a report on Thursday, May 28th. Finally, Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $21.93.
Bath & Body Works Stock Performance
NYSE:BBWI opened at $17.44 on Monday. The company has a 50-day moving average of $18.58 and a 200-day moving average of $20.07. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $33.96. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 4.90, a PEG ratio of 1.73 and a beta of 1.42.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts forecast that Bath & Body Works, Inc. will post 2.62 EPS for the current year.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Investors of record on Friday, June 5th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, June 5th. This represents a $0.80 annualized dividend and a yield of 4.6%. Bath & Body Works’s payout ratio is currently 22.47%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
See Also
- Five stocks we like better than Bath & Body Works
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
